Delivery Order SPE2DB22D1002-SPE2DB25FLJB3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action under a larger vehicle, this delivery order falls within AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3ml syringes, with a contract ceiling value of $2,220.84 and an ultimate completion date of March 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is a child...
- The Defense Logistics Agency awarded a $12,621.20 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12-year-old formulation, 0.3mL syringes) with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed from the vendor's location...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract valued at $22,175.70 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of COMIRNATY (COVID-19 vaccine) for individuals aged 12 and above, with a completion date of February 16, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply the vaccines from its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,002.50 delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 mL, with a completion date of November 15, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.60 to AmerisourceBergen Drug Corp for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizing firm fixed price delivery order contract terms. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and was awarded competitively without set-aside designation. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,270.30, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML, with a performance period ending on April 29, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY 2023-24 (12 and up) syringes (0.3 mL). The $2,009.97 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLJB3Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,262.12 for Comirnaty 2025-26 (12 years and up) in 0.3 mL syringes, with an ultimate completion date of October 16, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor at its Conshohocken, Pennsylvania location. The award represents a continuation of pharmaceutical supply deliveries under AmerisourceBergen's broader federal medical procurement activities with the Defense Logistics Agency. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/24/25 |